How can patients and clinicians effectively manage diabetic neuropathic pain in 2024? At the French Diabetes Society congress, three experts provided a comprehensive overview of the treatment for ...

Explore the latest guidelines for treating neuropathic pain, based on a comprehensive study by the International Association for the Study of Pain’s NeuPSIG. This research evaluates both drug and ...

In a recent study published in PNAS, researchers investigated the selective activity of sigmoid 2 receptor (σ2R) or transmembrane protein 97 (TMEM97) ligands on murine neuropathic pain models, their ...

Neuropathic pain in individuals with cancer remains a challenging clinical problem that requires advanced pharmacologic skills and a clear understanding of the molecular mechanisms that drive it. At ...

In the ongoing search to find a pain intervention that does away with the need for opioids – and bypasses drugs altogether – a new game-based system has shown huge promise in tackling chronic ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

America has a chronic pain problem. While there has been increased attention, in both policy and drug development, on non-opioid treatments, the focus has been on managing acute pain. The current ...

Lexicon Pharmaceuticals announced that it will present data on diabetic peripheral neuropathic pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025) in ...

Chronic pain affects over 50 million adults in the U.S. alone and is a leading cause of disability worldwide (Dahlhamer et al., 2018). Yet not all chronic pain is the same, and understanding what kind ...